Johnson & Johnson Announces Collaboration with U.S. Department of Health & Human Services to Accelerate Development of a Potential Novel Coronavirus Vaccine

NEW BRUNSWICK, N.J., February 11, 2020 – Johnson &Johnson today announced that its Janssen Pharmaceutical Companies will further expedite its investigational coronavirus vaccine program through an expanded collaboration with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health &Human Services. The collaborative partnership with BARDA builds on Johnson &Johnson’s multipronged response to the new coronavirus disease (COVID-19) outbreak. In addition to Janssen’s efforts to develop a vaccine candidate, the Company is working closely with global partners to screen its library of antiviral molecules to accelerate the discovery of potential COVID-19 treatments and provide relief for people in China and around the world.“Developing an effective vaccine will be critical if we are to protect people against the novel coronavirus and combat future outbreaks,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson &Johnson. “This partnership will ensure that vital research is made possible at rapid speed and underscores the importance of public-private partnerships to tackle the worldwide novel coronavirus epidemic. We are also in discussions with other partners, that if we have a vaccine candidate with potential, we aim to make it accessible to China and othe...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news

Related Links:

Publication date: Available online 14 February 2020Source: The Journal of Steroid Biochemistry and Molecular BiologyAuthor(s): Hong Chen, Qianru Zhang, Ruimin Chen, Xin Yuan, Xiangquan Lin, Xiaohong Yang, Ying ZhangAbstractCongenital adrenal hyperplasia (CAH) encompasses a group of autosomal recessive diseases characterized by enzymatic defects in steroid synthesis. Lipoid congenital adrenal hyperplasia (LCAH) is the most severe form of CAH, insofar as the initial step of steroid synthesis is impaired. Variants in the steroid acute regulatory (STAR) gene are responsible for LCAH. To describe the clinical and genetic charac...
Source: The Journal of Steroid Biochemistry and Molecular Biology - Category: Biochemistry Source Type: research
This study sheds light on a straightforward avenue to optimize the faradaic activity and nanoarchitecture for advanced supercapacitors.Graphical abstractHighly active N, O-doped hierarchical porous carbons are developed to optimize the physical adsorption and faradaic activity for efficient energy storage.
Source: Chinese Chemical Letters - Category: Chemistry Source Type: research
Publication date: Available online 14 February 2020Source: Chinese Chemical LettersAuthor(s): Hui Hu, Dashuai Zhang, Huiling Liu, Yaoqiang Jin, Jun Gao, Yongzheng Zhang, Zhongmin Liu, Xiuling Zhang, Longlong Geng, Suijun Liu, Ranhui ZhangAbstractTwo isostructural Ni(II)/Co(II)-based metal-organic frameworks (MOFs), namely {[M3(L)2(bpb)3(H2O)4]·2DMF·2H2O}n [M = Ni (HL-5, HL is short for Hui-Ling Liu); M = Co (HL-6); H3L = 2′,6′-dimethyl-[1,1′-biphenyl]-3,4′,5-tricarboxylic acid; bpb = 1,4-bis(pyrid-4-yl)benzene], have been hydrothe...
Source: Chinese Chemical Letters - Category: Chemistry Source Type: research
Publication date: Available online 14 February 2020Source: Chinese Chemical LettersAuthor(s): Zelong Wang, Lei Chen, Guoliang Mao, Congyang WangABSTRACTManganese-catalyzed hydrogenation of unsaturated molecules has made tremendous progresses recently on the benefits of non-innocent pincer or bidentate ligands for manganese. Herein, we describe the hydrogenation of quinolines and imines catalyzed by simple manganese carbonyls, Mn2(CO)10 or MnBr(CO)5, thus eliminating the prerequisite pincer-type or bidentate ligands.Graphical abstractEarth-abundant manganese catalysis can now enable hydrogenation of quinolines and imines by...
Source: Chinese Chemical Letters - Category: Chemistry Source Type: research
Publication date: 15 February 2020Source: New Scientist, Volume 245, Issue 3269Author(s): Debora MacKenzie
Source: New Scientist - Category: Science Source Type: research
Publication date: 15 February 2020Source: New Scientist, Volume 245, Issue 3269Author(s): Michael Le PageAs the coronavirus spreads in countries other than China, no nation is fully prepared for a pandemic, reports Michael Le Page
Source: New Scientist - Category: Science Source Type: research
Publication date: 15 February 2020Source: New Scientist, Volume 245, Issue 3269Author(s): Debora MacKenzieWhile the coronavirus death rate may be lower than some estimates, case numbers may be far higher, reports Debora MacKenzie
Source: New Scientist - Category: Science Source Type: research
rup S PMID: 32057331 [PubMed - in process]
Source: Vaccine - Category: Allergy & Immunology Authors: Tags: Vaccine Source Type: research
CONCLUSION: Our results demonstrated lower than expected seroprotection against measles among vaccinated children. Understanding the factors that affect host immunity to measles will aid in developing more efficient and effective immunization programs in DRC. PMID: 32057333 [PubMed - in process]
Source: Vaccine - Category: Allergy & Immunology Authors: Tags: Vaccine Source Type: research
Response to Letter to the editor by Signe Sørup re: The risk of non-specific hospitalised infections following MMR vaccination given with and without inactivated vaccines in the second year of life. Comparative self-controlled case-series study in England. Vaccine. 2020 Feb 24;38(9):2116 Authors: Andrews N, Stowe J, Walker J, Thomas S, Miller L PMID: 32057332 [PubMed - in process]
Source: Vaccine - Category: Allergy & Immunology Authors: Tags: Vaccine Source Type: research
More News: Allergy & Immunology | Brain | Cancer & Oncology | Cardiology | Cardiovascular | China Health | Congo Health | Coronavirus | Databases & Libraries | Department of Health | Ebola | Ebola Vaccine | Environmental Health | Epidemics | Epidemiology | Funding | Health Management | Heart | Hypertension | Infectious Diseases | International Medicine & Public Health | Learning | Legislation | Neurology | Neuroscience | Outbreaks | Partnerships | Pharmaceuticals | Prezista | Pulmonary Hypertension | Respiratory Medicine | Rwanda Health | Science | Study | Universities & Medical Training | USA Health | Vaccines | Zika Virus